Tnfi

Tapering TNFi in Psoriatic Arthritis and Axial Spondyloarthritis

ORAL Surveillance trial: risk of cardiovascular events with tofacitinib vs TNFi in patients with RA

Annals of the Rheumatic Diseases

Discussing Rheumatology: JAKi and TNFi

The Immune-Mediated Inflammatory Disease Forum

Perspectives on TNFi and RA: Dr. Jon Giles

Tapering TNFi in nonradiographic AxSpA

Which is better for AxSpA? IL-17i or TNFi?

TNFi in PsA and AxSpA: To Taper or Not?

Dose Tapering of TNFi in AxSpA: Dr. Antoni Chan

Bimekizumab treatment in patients with psoriatic arthritis and TNFi-IR: results up to 1 year

TNFi in axSpA: Dr. Swetha Alexander

Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles

TNFi in RA ILD: Avoid or Tolerate?

Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating First-Line TNFi Therapy

Non-TNFi b/tsDMARDs vs. TNFi in RA-ILD

Are TNFi and MTX additive or synergistic in PsA?

RWCS

Achieving Efficacy With Second TNFi in Patients With RA and Primary TNFi Failure

Rheumatology Advisor

EULAR 2019 - Press conference: Incidence of cancer in TNFi-treated patients with PsA

What is tumor necrosis factor alpha (TNFa)?

The Devil Is In The Details

Chronic Inflammation causes Fat Based Insulin Resistance

Tumor necrosis factor-alpha 308 G/A polymorphism and type 2 diabetes mellitus; a syst... | RTCL.TV

Medicine RTCL TV